| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |